Panome Bio
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $6M
Investors
- 2
About Panome Bio
Based in Missouri, US, and founded in 2022 by its Chief Scientific Officer, Gary J., operates as a biomarker discovery platform that offers various biomarker analysis, including metabolomics, lipidomic, and proteomics screening solutions. Panome Bio offers various metabolomics, lipidomics, and proteomics screening services that include lipid analysis, isotope-tracer analysis, mapping drug targets, and longitudinal analysis, along with a detailed report. The company’s platform also provides sample testing for serum and plasma, cell pellets, tissue sections, and other biofluids from multiple organisms.
Who invested in Panome Bio
2 investors across 1 round
See all investors in Panome Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 15, 2023
Amount
$6M
Investors
Questions about Panome Bio
Who invested in Panome Bio?
Panome Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Panome Bio raised?
Panome Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Panome Bio last raise money?
Panome Bio's most recent round on record is a Series A, in Feb 2023.
What does Panome Bio do?
Based in Missouri, US, and founded in 2022 by its Chief Scientific Officer, Gary J.
Where is Panome Bio headquartered?
Panome Bio is headquartered in St. Louis, US.
Which VCs invest in companies like Panome Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Panome Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Panome Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.